Growth Metrics

Catalyst Pharmaceuticals (CPRX) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 33.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.60%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -154.28%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.53%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 29.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 29.18%
Dec 31, 2025 27.42%
Sep 30, 2025 32.39%
Jun 30, 2025 34.08%
Mar 31, 2025 62.42%
Dec 31, 2024 81.80%
Sep 30, 2024 61.96%
Jun 30, 2024 49.61%
Mar 31, 2024 44.82%
Dec 31, 2023 44.97%
Sep 30, 2023 -39.42%
Jun 30, 2023 56.88%
Mar 31, 2023 41.55%
Dec 31, 2022 47.55%
Sep 30, 2022 18.62%
Jun 30, 2022 25.41%
Mar 31, 2022 182.50%
Dec 31, 2021 38.24%
Sep 30, 2021 49.15%
Jun 30, 2021 59.29%
Mar 31, 2021 49.55%
Dec 31, 2020 60.35%
Sep 30, 2020 131.30%
Jun 30, 2020 65.35%
Mar 31, 2020 60.04%
Dec 31, 2019 57.47%
Sep 30, 2019 75.95%
Jun 30, 2019 63.85%
Mar 31, 2019 50.72%
Dec 31, 2018 -35.60%
Sep 30, 2018 -20.78%
Jun 30, 2018 -9.38%
Mar 31, 2018 -1.75%
Dec 31, 2017 -15.57%
Sep 30, 2017 5.88%
Jun 30, 2017 -6.65%
Mar 31, 2017 -9.23%
Dec 31, 2016 -45.39%
Sep 30, 2016 12.55%
Jun 30, 2016 -13.27%
Mar 31, 2016 -45.62%
Dec 31, 2015 -323.45%
Sep 30, 2015 -19.28%
Jun 30, 2015 -150.77%
Mar 31, 2015 -70.62%
Dec 31, 2014 -14.06%
Sep 30, 2014 -64.38%
Jun 30, 2014 -31.88%
Mar 31, 2014 -35.94%
Dec 31, 2013 -22.96%
Sep 30, 2013 -87.01%